
Group 1 - Castle Biosciences, Inc. has been recognized for its innovative tests that guide patient care, with its CEO Derek Maetzold receiving a Lifetime Achievement Award in the Management: Business Products Industries category at the 2025 American Business Awards [3][4] - The Stevie Awards, which honor outstanding business performances in the U.S., received over 3,600 nominations this year, with gold awards representing the highest level of achievement [4][7] - Under Derek Maetzold's leadership, Castle Biosciences has evolved from a startup to an industry leader, significantly impacting how clinicians care for patients [5][12] Group 2 - The company focuses on molecular diagnostics and precision medicine, aiming to transform disease management by prioritizing patients, clinicians, employees, and investors [9][10] - Castle Biosciences' current portfolio includes tests for skin cancers, Barrett's esophagus, and uveal melanoma, with ongoing R&D for additional tests in high clinical need areas [10] - The company has been recognized as a Top Workplace USA for four consecutive years, reflecting its strong organizational culture [6][12]